Abstract
The aim of this study was to assess the impact of fatigue on the quality of life of patients with chronic hepatitis C (CHC) and to examine its relationship with various parameters of the disease, including viral load. The Fatigue Impact Scale (FIS), a self-report questionnaire, was applied to 92 patients with CHC, and the results were compared to those of an age-matched cohort of 213 healthy blood donors. Fatigue was frequent and disabling, being present in 67% of CHC patients, and the FIS was significantly increased in CHC patients compared to the healthy controls. Fatigue severity was not correlated with the activity of the disease or with the level of viremia. The FIS proved to be a valuable tool to assess this symptom. It should be of help for better evaluation of the clinical spectrum of the disease and should be included in trials assessing the efficacy of therapeutic interventions.
Similar content being viewed by others
REFERENCES
Anonymous: Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6:35–47, 1999
Alberti A, Chemello L, Benvegnù L: Natural history of hepatitis C. J Hepatol 31:17–24, 1999
Shakil AO, Conry-Cantilena C, Alter HJ: Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 123:330–337, 1995
Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463–1466, 1995
Tong MJ, El-Farra NS: Clinical sequelae of hepatitis C acquired from injection drug use. West J Med 164:399–404, 1996
Kenny-Walsh E for the Irish Hepatology Study Group: Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 340:1228–1233, 1999
Barkhuizen A, Rosen HR, Wolf S, flora K, Benner K, Bennett RM: Musculoskeletal pain and fatigue are associated with chronic hepatitis C. A report of 239 hepatology clinic patients. Am J Gastroenterol 94:1355–1360, 1999
EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 31:3–8, 1999
Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ: The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21:9–14, 1994
Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF: Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18:S79–S83, 1994
Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J: Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 95:760–767, 2000
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435, 1981
Hoofnagle JH. Hepatitis C: The clinical spectrum of the disease. Hepatology 26:15S-20S, 1997
Merican I, Sherlock S, McIntyre N, Dusheiko GM: Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med 86:119–125, 1993
Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J: Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 11:833–838, 1999
Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ: Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res 49:311–317, 2000
Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL: Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 16:334–343, 1994
Carithers RL, Sugano D, Bayliss M: Health assessment for chronic HCV infection. Results of quality of life. Dig Dis Sci 41:75S-80S, 1996
Hunt CM, Dominitz JA, Philips Bute B, Waters B, Blasi U, Williams DM: Effect of interferon-α treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci 42:2482–2486, 1997
Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE: A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 7:39–55, 1998
Foster GR, Goldin RD, Thomas HC: Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27:209–212, 1998
Bonkovsky HL, Woolley JM, Consensus Interferon Study Group: Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 29:264–270, 1999
Ware JE, Bayliss MS, Mannocchia M, Davis GL: Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Hepatology 30:550–555, 1999
Neary MP, Cort S, Bayliss MS, Ware JE: Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients. Semin Liver Dis 19:77–85, 1999
McHutchinson JG, Ware JE, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, Neary MP: The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 34:140–147, 2001
Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD: Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38–39, 2001
Gershon AS, Margulies M, Gorczynski RM, Heathcote EJ: Serum cytokine values and fatigue in chronic hepatitis C infection. J Viral Hepat 7:397–402, 2000
Jones EA: Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C. Med Hypotheses 57:133–134, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hassoun, Z., Willems, B., Deslauriers, J. et al. Assessment of Fatigue in Patients with Chronic Hepatitis C Using the Fatigue Impact Scale. Dig Dis Sci 47, 2674–2681 (2002). https://doi.org/10.1023/A:1021040702370
Issue Date:
DOI: https://doi.org/10.1023/A:1021040702370